Media Room--We can provide journalists with expert commentary on topics like:  

  • Challenges facing early career scientists, and new technologies and trends in cancer research (all forms of cancer)
  • Connections to bright, articulate early career scientists involved in leading-edge cancer research projects
  • Introductions to scientists and doctors nationwide, and interviews with our President and CEO, Chief Scientific Officer, or others

Contact: Yung S. Lie, PhD, Deputy Director and Chief Scientific Officer, yung.lie@damonrunyon.org, 212.455.0521 

Press releases are listed below.  Visit New Discoveries for breakthroughs from our scientists.

Mission: To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. The Foundation supports emerging leaders who have great potential to achieve breakthroughs in how we diagnose, treat and prevent cancer. Since its founding in 1946, the Foundation has invested over $340 million and funded over 3,650 young scientists. 100% of all donations to the Foundation are used to support scientific research. 

April 4, 2014

More than 700 people – from those affected by cancer to professional stair climbers – took part in the Damon Runyon Cancer Research Foundation’s first ever Runyon Up stair climb at the new 4 World Trade Center building on April 3rd, raising more than $173,000 for young cancer researchers.


March 11, 2014

The Damon Runyon Cancer Research Foundation held the third annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to sidestep many of the issues that currently impede progress against cancer. Hosted by Genentech, the meeting included academic researchers from top universities and research institutions as well as scientists from Eli Lilly and Company, Celgene, Merck, Pfizer, and Takeda Pharmaceuticals International Co.  


January 21, 2014

The Damon Runyon Cancer Research Foundation, announced that six scientists with novel approaches to fighting cancer have been named 2014 recipients of the Damon Runyon-Rachleff Innovation Award.  The grant of $450,000 over three years is awarded each year to early career scientists whose projects have the potential to significantly impact the prevention, diagnosis and treatment of cancer. 


January 13, 2014

The Damon Runyon Cancer Research Foundation named 15 new Damon Runyon Fellows at its fall Fellowship Award Committee review. The recipients of this prestigious, three-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Committee also named five new recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists.  This award provides additional funding to scientists completing a prestigious Damon Runyon Fellowship Award who have greatly exceeded the Foundation’s highest expectations and are most likely to make paradigm-shifting breakthroughs that transform the way we prevent, diagnose and treat cancer. 


  • Support the next generation of researchers.